|
"mizokami a"的相關文件
顯示項目 1-10 / 12 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2022-12-07 |
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis
|
Kano, H;Izumi, K;Hiratsuka, K;Toriumi, R;Nakagawa, R;Aoyama, S;Kamijima, T;Shimada, T;Naito, R;Kadomoto, S;Iwamoto, H;Yaegashi, H;Kawaguchi, S;Nohara, T;Shigehara, K;Kadono, Y;Saito, Y;Nakagawa-Goto, K;Yoshioka, K;Nakata, H;Lin, WJ;Mizokami, A |
| 臺大學術典藏 |
2021-01-26T02:28:02Z |
Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells
|
Yeh S.;Kang H.-Y.;Miyamoto H.;Nishimura K.;Hong-Chiang Chang;Ting H.-J.;Rahman M.;Lin H.-K.;Fujimoto N.;Hu Y.-C.;Mizokami A.;Huang K.-E.;Chang C.; Yeh S.; Kang H.-Y.; Miyamoto H.; Nishimura K.; HONG-CHIANG CHANG; Ting H.-J.; Rahman M.; Lin H.-K.; Fujimoto N.; Hu Y.-C.; Mizokami A.; Huang K.-E.; Chang C. |
| 臺大學術典藏 |
2021-01-26T02:28:01Z |
Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate
|
Fujimoto N.;Yeh S.;Kang H.-Y.;Inui S.;Hong-Chiang Chang;Mizokami A.;Chang C.; Fujimoto N.; Yeh S.; Kang H.-Y.; Inui S.; HONG-CHIANG CHANG; Mizokami A.; Chang C. |
| 臺大學術典藏 |
2021-01-26T02:27:54Z |
Expression of human AR cDNA driven by its own promoter results in mild promotion, but not suppression, of growth in human prostate cancer PC-3 cells
|
Altuwaijri S.;Wu C.-C.;Niu Y.-J.;Mizokami A.;Hong-Chiang Chang;Chang C.; Altuwaijri S.; Wu C.-C.; Niu Y.-J.; Mizokami A.; HONG-CHIANG CHANG; Chang C. |
| 國家衛生研究院 |
2018-11-13 |
CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer clls
|
Natsagdorj, A;Izumi, K;Hiratsuka, K;Machioka, K;Iwamoto, H;Naito, R;Makino, T;Kadomoto, S;Shigehara, K;Kadono, Y;Lin, WJ;Maolake, A;Mizokami, A |
| 國家衛生研究院 |
2017-12-30 |
CCL5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment
|
Urata, S;Izumi, K;Hiratsuka, K;Maolake, A;Natsagdorj, A;Shigehara, K;Iwamoto, H;Kadomoto, S;Makino, T;Naito, R;Kadono, Y;Lin, WJ;Wufuer, G;Narimoto, K;Mizokami, A |
| 國家衛生研究院 |
2017-02 |
Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22-CCR4 axis
|
Maolake, A;Izumi, K;Shigehara, K;Natsagdorj, A;Iwamoto, H;Kadomoto, S;Takezawa, Y;Machioka, K;Narimoto, K;Namiki, M;Lin, WJ;Wufuer, G;Mizokami, A |
| 國家衛生研究院 |
2016-02 |
Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer
|
Izumi, K;Mizokami, A;Lin, HP;Ho, HM;Iwamoto, H;Maolake, A;Natsagdorj, A;Kitagawa, Y;Kadono, Y;Miyamoto, H;Huang, CK;Namiki, M;Lin, WJ |
| 國家衛生研究院 |
2014-08 |
Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level
|
Izumi, K;Lin, WJ;Miyamoto, H;Huang, CK;Maolake, A;Kitagawa, Y;Kadono, Y;Konaka, H;Mizokami, A;Namiki, M |
| 國家衛生研究院 |
2013-09 |
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
|
Izumi, K;Fang, LY;Mizokami, A;Namiki, M;Li, L;Lin, WJ;Chang, C |
顯示項目 1-10 / 12 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目
|
